Newleos Therapeutics
PrivateLast Round
Series A
Feb 13, 2025
Total Funding Raised
$93.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Newleos Therapeutics is a clinical-stage biotechnology company that develops oral small-molecule therapies for neuropsychiatric disorders including anxiety and substance use disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newleos Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Newleos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2025 |
Key People
Founding team and executive leadership
Newleos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A |
| Novo Holdings | Series A |
| Arkin Bio Capital | Series A |
| Longwood Fund | Series A |
| Goldman Sachs Alternatives | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Grew 16% QoQ, from 25 to 29 employees.
Newleos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Newleos Therapeutics's valuation, stock price, and market status.